Trial Profile
Tipranavir: An Open-label, Randomized Study Comparing Combination Therapy (Tipranavir and Ritonavir vs. Saquinavir and Ritonavir) Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Tipranavir (Primary) ; Ritonavir; Saquinavir
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Boehringer Ingelheim
- 05 Nov 2010 New trial record.